+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2022-2026 USA Respiratory Disease Market: Shares and Segment Forecasts

  • PDF Icon

    Report

  • February 2022
  • Region: United States
  • VPG Market Research
  • ID: 5556146
This new report provides analysis of the US respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.

About this Report


This report presents detailed analysis of the Respiratory Disease market in France.

Current scientific views on epidemiology and etiology are presented for:

  • Adenovirus
  • Coronavirus
  • Enterovirus
  • Influenza
  • Legionella
  • Mononucleosis
  • Mycoplasma
  • Pneumonia
  • RSV
  • Rhinovirus
  • Tuberculosis

The report provides test volume and sales forecasts by country and market segment.

The report is available by section, and can be customized to specific information needs and budget.

In addition to market share and sales forecasts, the report:

  • Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.
  • Reviews features and operating characteristics of major analyzers used for respiratory disease testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology


In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.